Insider Purchases: Inside the Buy

Tag: hub-overseas

Illustration of a stylized crown hovering above biotech molecules and financial charts, representing XOMA Royalty’s strategy of collecting biotech royalties without developing drugs.

Can XOMA Become Royalty? The CEO, BVF Partners, and Morgan Stanley Think So!

XOMA Royalty doesn’t run clinical trials—it collects royalties. With a $2.5M CEO insider buy, heavyweight institutional backing, and improving cash flow, this biotech quiet achiever may be turning into something… royal.

Read entire article

Tags: Biotech Royalties, Biotech Stocks, buy-or-sell-XOMA, CEO buy, CEO Buys, CEO Conviction, CEO insider buying, CEO Insider Purchases, CEO Stock Purchase, CEOBuyIn, CEOConfidence, featured-insiders, funanc1al edge, funanc1al humor, FUNanc1al Investing, FUNstock Income + Growth, Healthcare Investing, hub-diversify, hub-epiphany, hub-fun, hub-hedge, hub-insiders, hub-ipos, hub-overseas, hub-ridiculous, hub-special-files, hub-value, Insider Buying, risks-investing-in-xoma, Royalty Stocks, Small-Cap Stocks, why-buy-xoma, XOMA, XOMA Royalty
Playful illustration of a Lyft car sprouting wings, symbolizing stock lift-off potential against bigger Uber competition.

Lyft’s CEO Keeps Buying Shares. Are They About to Lift Off?

Lyft’s CEO keeps buying stock while hedge funds pile in. With profits, free cash flow, and share buybacks, could LYFT finally lift off—or hit roadblocks? 🚗📈

Read entire article

Tags: Autonomous Vehicles, CEO Buys, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, Free Cash Flow, Funanc1al, FUNanc1al Edge, Funanc1al humor, FUNanc1al Investing, Growth Stocks, Hedge Fund Moves, hub-overseas, Insider Buying, Is Lyft a Buy, John David Risher, Lyft Stock, Rideshare Stocks, Transportation Tech, Uber vs Lyft